Novartis’ AveXis shifted top scientific leadership before Zolgensma data scandal erupted

14th August 2019 Uncategorised 0

Novartis has said it shuffled staff at its under-the-gun gene therapy unit AveXis. Now we know who and when, at least when it comes to its top scientific leaders. A Novartis research exec, Page Bouchard, took the R&D helm at AveXis Aug. 5, replacing two scientists involved in the Zolgensma data manipulation.

More: Novartis’ AveXis shifted top scientific leadership before Zolgensma data scandal erupted
Source: fierce